Weaver C. Barksdale & Associates, Inc. Quest Diagnostics Inc Transaction History

Weaver C. Barksdale & Associates, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$123.31 - $157.26 $45,378 - $57,871	368 Added 2.6%	14,508 $2.27 Million
Q3 2022 Nov 14, 2022	SELL	$121.77 - $141.1 $62,346 - $72,243	-512 Reduced 3.49%	14,140 $1.74 Million
Q2 2022 Aug 11, 2022	BUY	$127.07 - $145.39 $111,694 - $127,797	879 Added 6.38%	14,652 $1.95 Million
Q1 2022 May 16, 2022	BUY	$129.09 - $164.35 $23,494 - $29,911	182 Added 1.34%	13,773 $1.89 Million
Q4 2021 Feb 14, 2022	BUY	$140.36 - $173.01 $1.91 Million - $2.35 Million	13,591 New	13,591 $2.35 Million

933

93.8M

501K

238K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Weaver C. Barksdale & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Weaver C. Barksdale & Associates, Inc. with notifications on news.